Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

aminostigmine

Known as: Carbamic acid, dimethyl-, 2-((dimethylamino)methyl)-3-pyridinyl ester, dihydrochloride 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
We studied the effects of 2-(hexyl(methyl)amino)methyl)pyridyl-3-dimethyl carbamate (OPDC), a structural analogue of… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
1998
1998
The results of studying the pharmacokinetics of aminostigmine, a new reversible cholinesterase inhibitor produced in Russia, are… Expand
Is this relevant?
1996
1996
The results of application of cholinesterase inhibitors, aminostigmin and galantamin, for treatment of acute poisoning with… Expand
Is this relevant?
1996
1996
The properties of aminostigmine in comparison with those of other carbamate inhibitors of cholinesterases have been studied in… Expand
Is this relevant?
1996
1996
Aminostigmin, a novel reversible inhibitor of cholinesterase developed in Russia, has been tried in management of poisoning with… Expand
Is this relevant?
1995
1995
Sixteen aminostigmine derivatives containing various substituents at the nitrogen atom of the carbamoyl group have been prepared… Expand
Is this relevant?
1995
1995
This investigation has been carried out on albino mice. In the first series of experiments, we determined the dependence of LD50… Expand
Is this relevant?
1994
1994
Experiments on non-inbred albino mice have demonstrated that aminostigmine is an active reversible centrally active… Expand
Is this relevant?
1992
1992
The pharmacological properties of a new drug approved in the USSR for the treatment of cholinolytics poisonings are described… Expand
Is this relevant?
1991
1991
The effect of anesthesia with ketamine (80 mg/kg, intraperitoneally) combined with phenazepam (0.5 mg/kg, subcutaneously) on the… Expand
Is this relevant?